Yvonne Greenstreet
Chief Executive Officer at Alnylam Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alnylam Pharmaceuticals Inc. May 20, 202699.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 19, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +107 | — | — |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −135 | $319.03 | $43,069 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −129 | $320.01 | $41,281 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −274 | $320.81 | $87,902 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −368 | $321.82 | $118,430 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −444 | $323.01 | $143,416 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −973 | $323.84 | $315,096 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −345 | $324.88 | $112,084 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −265 | $325.67 | $86,303 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +13,844 | — | — |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −200 | $323.62 | $64,724 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −382 | $324.65 | $124,016 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,098 | $325.63 | $357,542 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,669 | $326.81 | $545,446 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,399 | $327.67 | $458,410 |
Questions about Yvonne Greenstreet
What boards is Yvonne Greenstreet on?
Yvonne Greenstreet sits on the board of Alnylam Pharmaceuticals Inc.
What company is Yvonne Greenstreet the CEO of?
Yvonne Greenstreet is Chief Executive Officer of Alnylam Pharmaceuticals Inc.
How long has Yvonne Greenstreet served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.